IQVIA Holdings, Inc. (IQV): Price and Financial Metrics
IQVIA Holdings, Inc. (IQV)
Today's Latest Price: $167.47 USD
Updated Oct 23 6:40pm
Add IQV to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
IQV Stock Summary
- With a market capitalization of $32,372,610,996, Iqvia Holdings Inc has a greater market value than 93.83% of US stocks.
- IQV's current price/earnings ratio is 245.25, which is higher than 96.98% of US stocks with positive earnings.
- The volatility of Iqvia Holdings Inc's share price is greater than that of only 19.39% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Iqvia Holdings Inc, a group of peers worth examining would be RSG, VRSK, LVS, NDAQ, and LH.
- Visit IQV's SEC page to see the company's official filings. To visit the company's web site, go to www.iqvia.com.
IQV Stock Price Chart Interactive Chart >
IQV Price/Volume Stats
| Current price | $167.47 | 52-week high | $176.00 |
| Prev. close | $169.40 | 52-week low | $81.79 |
| Day low | $166.53 | Volume | 760,500 |
| Day high | $170.77 | Avg. volume | 1,384,523 |
| 50-day MA | $160.91 | Dividend yield | N/A |
| 200-day MA | $146.45 | Market Cap | 32.03B |
IQVIA Holdings, Inc. (IQV) Company Bio
IQVIA provides biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through two segments, Product Development and Integrated Healthcare Services. The company was founded in 1982 and is based in Durham, North Carolina.
IQV Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $167.47 | $144.53 | -14% |
Below please find a table outlining a discounted cash flow forecast for IQV, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Iqvia Holdings Inc ranked in the 44th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for IQV, they are:
- The company's compound free cash flow growth rate over the past 5.7 years comes in at 0.24%; that's greater than 64.17% of US stocks we're applying DCF forecasting to.
- Relative to other stocks in its sector (Healthcare), Iqvia Holdings Inc has a reliance on debt greater than 67.53% of them.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -15% |
| 1% | -15% |
| 2% | -14% |
| 3% | -13% |
| 4% | -12% |
| 5% | -11% |
Want more companies with a valuation profile/forecast similar to that of Iqvia Holdings Inc? See DXCM, MCK, HBIO, AMED, and AMGN.
Loading social stream, please wait...